Wenhong Zhang, MD
Huashan Hospital
4
3
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Worked with same sponsors:
Min Xie
Guangzhou Eighth People's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jidong Jia, MD
Beijing Friendship Hospital
Shared therapeutic areas:
Worked with same sponsors:
Peng Hu, MD
The second affiliated hospital of chongqiong medical university
Shared therapeutic areas:
Worked with same sponsors:
Jun Li, MD
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University)
Shared therapeutic areas:
Worked with same sponsors:
Huazhong Chen, MM
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Shared therapeutic areas:
Worked with same sponsors:
Yao Xie, MD
Beijing Ditan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Xiaoqing Fu, MM
Hangzhou Xixi hospital
Shared therapeutic areas:
Worked with same sponsors:
Qin Zhang, MD
Shanghai Tong Ren Hospital
Shared therapeutic areas:
Worked with same sponsors:
Junqi Niu, MD
The First Hospital of Jilin University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China
All 4 trials loaded